Ewelina Waleka-Bargiel

Ms. Ewelina Waleka-Bargiel

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MMMarcin Mackiewicz
Marcin Mackiewicz
JRJan Romanski
Jan Romanski
KDKinga Drabczyk
Kinga Drabczyk
EWEwelina Waleka-Bargiel
Ewelina Waleka-Bargiel
ZSZbigniew Stojek
Zbigniew Stojek
MKMarcin Karbarz
Marcin Karbarz

4 May 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
EWEwelina Waleka-Bargiel
Ewelina Waleka-Bargiel
ZSZbigniew Stojek
Zbigniew Stojek
MKMarcin Karbarz
Marcin Karbarz
Due to the unwanted toxic properties of some drugs, new efficient methods of protection of the organisms against that toxicity are required. New materials are synthesized to effectively disseminate the active substance without affecting the healthy cells. Thus far, a number of polymers have been applied to build novel drug delivery systems. One of interesting polymers for this purpose is povidone, pVP. Contrary to other polymeric materials, the synthesis of povidone nanoparticles can take place under various condition, due to good solubility of this polymer in several organic and inorganic solvents. Moreover, povidone is known as nontoxic, non-carcinogenic, and temperature-insensitive substance. Its flexible design and the presence of various functional groups allow connection with the hydrophobic and hydrophilic drugs. It is worth noting, that pVP is regarded as an ecofriendly substance. Despite wide application of pVP in medicine, it was not often selected for the production of drug carriers. This review article is focused on recent reports on the role povidone can play in micro- and nano drug delivery systems. Advantages and possible threats resulting from the use of povidone are indicated. Moreover, popular biomedical aspects are discussed.